Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 166

2.

In Vitro Synergistic Effects of Antimicrobial Combinations on Extensively Drug-Resistant Pseudomonas aeruginosa and Acinetobacter baumannii Isolates.

Lee H, Roh KH, Hong SG, Shin HB, Jeong SH, Song W, Uh Y, Yong D, Lee K.

Ann Lab Med. 2016 Mar;36(2):138-44. doi: 10.3343/alm.2016.36.2.138.

3.

Epidemiological, Physiological, and Molecular Characteristics of a Brazilian Collection of Carbapenem-Resistant Acinetobacter baumannii and Pseudomonas aeruginosa.

Dias VC, Resende JA, Bastos AN, De Andrade Bastos LQ, De Andrade Bastos VQ, Bastos RV, Diniz CG, Da Silva VL.

Microb Drug Resist. 2017 Oct;23(7):852-863. doi: 10.1089/mdr.2016.0219. Epub 2017 Feb 24.

PMID:
28437232
4.

Antimicrobial-resistant Pseudomonas aeruginosa and Acinetobacter baumannii From Patients With Hospital-acquired or Ventilator-associated Pneumonia in Vietnam.

Biedenbach DJ, Giao PT, Hung Van P, Su Minh Tuyet N, Thi Thanh Nga T, Phuong DM, Vu Trung N, Badal RE.

Clin Ther. 2016 Sep;38(9):2098-105. doi: 10.1016/j.clinthera.2016.07.172. Epub 2016 Sep 6.

PMID:
27612610
5.

Genotypic diversity among multidrug resistant Pseudomonas aeruginosa and Acinetobacter species at Mulago Hospital in Kampala, Uganda.

Kateete DP, Nakanjako R, Okee M, Joloba ML, Najjuka CF.

BMC Res Notes. 2017 Jul 14;10(1):284. doi: 10.1186/s13104-017-2612-y.

6.
7.
8.

Prevalence and Molecular Characterization of New Delhi Metallo-Beta-Lactamases in Multidrug-Resistant Pseudomonas aeruginosa and Acinetobacter baumannii from India.

Rahman M, Prasad KN, Gupta S, Singh S, Singh A, Pathak A, Gupta KK, Ahmad S, Gonzalez-Zorn B.

Microb Drug Resist. 2018 Jul/Aug;24(6):792-798. doi: 10.1089/mdr.2017.0078. Epub 2017 Oct 23.

PMID:
29058515
9.

Longitudinal survey of carbapenem resistance and resistance mechanisms in Enterobacteriaceae and non-fermenters from the USA in 2007-09.

Davies TA, Marie Queenan A, Morrow BJ, Shang W, Amsler K, He W, Lynch AS, Pillar C, Flamm RK.

J Antimicrob Chemother. 2011 Oct;66(10):2298-307. doi: 10.1093/jac/dkr290. Epub 2011 Jul 20.

PMID:
21775338
10.

Update on Pseudomonas aeruginosa and Acinetobacter baumannii infections in the healthcare setting.

Navon-Venezia S, Ben-Ami R, Carmeli Y.

Curr Opin Infect Dis. 2005 Aug;18(4):306-13. Review.

PMID:
15985826
11.

The diversity of definitions of multidrug-resistant (MDR) and pandrug-resistant (PDR) Acinetobacter baumannii and Pseudomonas aeruginosa.

Falagas ME, Koletsi PK, Bliziotis IA.

J Med Microbiol. 2006 Dec;55(Pt 12):1619-29. Review.

PMID:
17108263
12.

Emerging broad-spectrum resistance in Pseudomonas aeruginosa and Acinetobacter baumannii: Mechanisms and epidemiology.

Potron A, Poirel L, Nordmann P.

Int J Antimicrob Agents. 2015 Jun;45(6):568-85. doi: 10.1016/j.ijantimicag.2015.03.001. Epub 2015 Mar 24. Review.

PMID:
25857949
13.

Risk factors of multidrug-resistant, extensively drug-resistant and pandrug-resistant Acinetobacter baumannii ventilator-associated pneumonia in a Medical Intensive Care Unit of University Hospital in Thailand.

Inchai J, Liwsrisakun C, Theerakittikul T, Chaiwarith R, Khositsakulchai W, Pothirat C.

J Infect Chemother. 2015 Aug;21(8):570-4. doi: 10.1016/j.jiac.2015.04.010. Epub 2015 May 7.

PMID:
26026660
14.

Pan Drug-Resistant Environmental Isolate of Acinetobacter baumannii from Croatia.

Goic-Barisic I, Seruga Music M, Kovacic A, Tonkic M, Hrenovic J.

Microb Drug Resist. 2017 Jun;23(4):494-496. doi: 10.1089/mdr.2016.0229. Epub 2016 Oct 28.

PMID:
27792476
15.

Impact of antibiotic exposure on occurrence of nosocomial carbapenem-resistant Acinetobacter baumannii infection: a case control study.

Chusri S, Silpapojakul K, McNeil E, Singkhamanan K, Chongsuvivatwong V.

J Infect Chemother. 2015 Feb;21(2):90-5. doi: 10.1016/j.jiac.2014.10.002. Epub 2014 Nov 25.

PMID:
25454216
16.

Carbapenem resistance in Pseudomonas aeruginosa and Acinetobacter baumannii in the nosocomial setting in Latin America.

Labarca JA, Salles MJ, Seas C, Guzmán-Blanco M.

Crit Rev Microbiol. 2016;42(2):276-92. doi: 10.3109/1040841X.2014.940494. Epub 2014 Aug 27. Review.

PMID:
25159043
17.
18.

Antimicrobial susceptibility patterns of multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii against carbapenems, colistin, and tigecycline.

Somily AM, Absar MM, Arshad MZ, Al Aska AI, Shakoor ZA, Fatani AJ, Siddiqui YM, Murray TS.

Saudi Med J. 2012 Jul;33(7):750-5.

PMID:
22821309
19.

Emergence of carbapenem-resistant Acinetobacter baumannii in hospitals in Pakistan.

Hasan B, Perveen K, Olsen B, Zahra R.

J Med Microbiol. 2014 Jan;63(Pt 1):50-5. doi: 10.1099/jmm.0.063925-0. Epub 2013 Oct 1.

PMID:
24085817
20.

Trend of extensively drug-resistant Acinetobacter baumannii and the remaining therapeutic options: a multicenter study in Tehran, Iran over a 3-year period.

Jasemi S, Douraghi M, Adibhesami H, Zeraati H, Rahbar M, Boroumand MA, Aliramezani A, Ghourchian S, Mohammadzadeh M.

Lett Appl Microbiol. 2016 Dec;63(6):466-472. doi: 10.1111/lam.12669. Epub 2016 Nov 2.

Supplemental Content

Support Center